Maluba, Junisa L.
HRN: 24-18-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2023
MEBENDAZOLE 500MG (TAB)
12/01/2023
12/02/2023
PO
500mg
Single Dose
Intestinal Parasitism
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes